Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -59.39%1.08B | ---- | 30.59%2.66B | 26.97%1.07B | -49.90%2.04B | -7.26%845.08M | 636.95%4.07B | 194.56%911.28M | 69.94%552.23M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -16.22%-64.36M | ---- | -59.43%-55.38M | ---- | -53.14%-34.73M | ---- | 15.97%-22.68M | ---- | -11.01%-26.99M |
| Interest expense - adjustment | ---- | 34.24%136.66M | ---- | -1.34%101.8M | ---- | -18.34%103.19M | --51.05M | -27.69%126.36M | ---- | -9.96%174.73M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | 146.18%81.26M | ---- | ---175.95M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 10.07%-177.9M | ---- | -37.20%-197.83M | ---- | -0.61%-144.19M | ---54.66M | -285.56%-143.32M | ---- | -237.16%-37.17M |
| Impairment and provisions: | ---- | ---- | ---- | 507.74%44.3M | ---- | -101.99%-10.86M | --19.2M | 4,753.20%545.55M | ---- | 171.15%11.24M |
| -Other impairments and provisions | ---- | ---- | ---- | 507.74%44.3M | ---- | -101.99%-10.86M | --19.2M | 4,753.20%545.55M | ---- | 171.15%11.24M |
| Revaluation surplus: | ---- | -2,259.98%-171.05M | ---- | -182.53%-7.25M | -296.09%-133.58M | -86.01%8.78M | --68.13M | -25.51%62.76M | ---- | --84.26M |
| -Derivative financial instruments fair value (increase) | ---- | -2,259.98%-171.05M | ---- | ---7.25M | -325.10%-133.58M | ---- | --59.34M | ---- | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | -86.01%8.78M | --8.78M | -25.51%62.76M | ---- | --84.26M |
| Asset sale loss (gain): | ---- | -170.42%-12.49M | ---- | 970.31%17.74M | ---- | -140.99%-2.04M | ---- | -81.54%4.97M | ---- | 167.84%26.93M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -170.42%-12.49M | ---- | 970.31%17.74M | ---- | -140.99%-2.04M | ---- | -81.54%4.97M | ---- | 167.84%26.93M |
| Depreciation and amortization: | ---- | 28.21%474.41M | ---- | 41.00%370.03M | ---- | 9.11%262.43M | --119.49M | 69.02%240.51M | ---- | 30.67%142.3M |
| -Depreciation | ---- | 25.56%450.32M | ---- | 40.87%358.65M | ---- | 9.15%254.61M | --119.49M | 72.33%233.26M | ---- | 33.20%135.36M |
| -Amortization of intangible assets | ---- | 111.77%24.1M | ---- | 45.54%11.38M | ---- | 7.79%7.82M | ---- | 4.42%7.25M | ---- | -4.57%6.95M |
| -Other depreciation and amortization | ---- | -21.81%-3.09M | ---- | 71.53%-2.54M | ---- | -213.05%-8.92M | ---- | ---2.85M | ---- | ---- |
| Exchange Loss (gain) | ---- | 172.08%8.67M | ---- | -109.59%-12.03M | ---- | 1,417.94%125.46M | --102.4M | -69.28%8.27M | ---- | 54.00%26.9M |
| Adjustment items | ---- | -21.81%-3.09M | ---- | 71.53%-2.54M | ---- | -213.05%-8.92M | ---- | ---2.85M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -56.46%1.27B | ---- | 20.76%2.92B | -18.36%939.45M | -48.67%2.42B | 26.27%1.15B | 393.82%4.71B | 194.56%911.28M | 51.03%954.44M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 183.53%1.4B | ---- | -356.92%-1.68B | 469.77%841.24M | 137.92%652.19M | 84.26%-227.51M | -381.12%-1.72B | -177.00%-1.45B | 316.53%611.82M |
| Accounts receivable (increase)decrease | ---- | 151.71%224.38M | ---- | -150.15%-433.89M | ---- | 141.53%865.11M | ---- | -301.82%-2.08B | ---- | 33.04%1.03B |
| Accounts payable increase (decrease) | ---- | -145.63%-811.28M | ---- | 255.11%1.78B | ---- | -155.79%-1.15B | ---- | 345.65%2.05B | ---- | 49.03%461M |
| Special items for working capital changes | ---- | -272.38%-1.09B | ---- | ---292.85M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | 160.19%1.63B | -56.71%994.37M | -64.77%627.3M | -17.69%2.3B | 92.89%1.78B | -5.87%2.79B | 272.83%923.18M | -3.11%2.96B | -124.43%-534.15M | 113.27%3.06B |
| Other taxs | 60.18%-98.89M | -30.41%-353.97M | -11.83%-248.36M | 56.09%-271.44M | 15.43%-222.08M | -199.86%-618.13M | -307.76%-262.58M | -119.02%-206.14M | -25.59%-64.4M | -96.50%-94.12M |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.23%56.29M | ---- |
| Special items of business | ---- | ---- | ---- | ---- | 7,601.38%157.15M | ---- | -102.61%-2.1M | ---- | 41.66%80.12M | ---- |
| Net cash from operations | 304.63%1.53B | -68.38%640.4M | -77.91%378.94M | -6.76%2.03B | 160.56%1.72B | -21.25%2.17B | 242.49%658.5M | -6.98%2.76B | -120.05%-462.14M | 113.85%2.97B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 129.46%28.08M | 5.71%49.21M | --12.24M | 31.94%46.55M | ---- | 35.86%35.28M | ---- | -13.70%25.97M | ---- | 138.95%30.09M |
| Dividend received - investment | -41.41%98.95M | 68.87%195.37M | 45.97%168.87M | 19.62%115.69M | 15.59%115.69M | 32.07%96.71M | 36.68%100.09M | 648.83%73.23M | 662.87%73.23M | --9.78M |
| Loan receivable (increase) decrease | 87.61%-15.28M | 29.73%-137.15M | 25.74%-123.37M | ---195.18M | ---166.13M | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | 105.75%26.6M | 55.08%-11.69M | -221.89%-462.44M | -118.87%-26.03M | -283.94%-143.66M | 287.23%137.92M | -122.40%-37.42M | -519.47%-73.66M | 159.84%167.01M | 103.52%17.56M |
| Sale of fixed assets | -89.85%13.12M | 695.67%196.36M | --129.24M | 45.30%24.68M | ---- | -23.76%16.99M | ---- | 308.23%22.28M | ---- | 139.76%5.46M |
| Purchase of fixed assets | -3.69%-512.73M | -16.34%-1.03B | -0.82%-494.51M | -39.38%-881.73M | -28.60%-490.46M | 2.23%-632.63M | -59.19%-381.38M | -38.51%-647.05M | -242.10%-239.58M | -65.90%-467.16M |
| Acquisition of subsidiaries | ---- | -338.20%-710.26M | ---112.56M | -912.96%-162.08M | ---- | ---16M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.98M |
| Cash on investment | 73.87%234.32M | 170.78%534.98M | 12.76%134.77M | -93.43%-755.84M | 189.64%119.52M | -373.50%-390.75M | -790.37%-133.33M | 191.12%142.87M | ---14.98M | 86.75%-156.8M |
| Other items in the investment business | ---- | ---- | ---- | ---- | -231.29%-20.93M | ---- | -29.68%15.94M | ---- | 30.90%22.67M | ---- |
| Net cash from investment operations | 83.02%-126.94M | 50.43%-909.01M | -27.61%-747.75M | -143.72%-1.83B | -34.36%-585.97M | -64.89%-752.48M | -5,319.05%-436.1M | 18.37%-456.37M | 102.59%8.36M | 70.98%-559.09M |
| Net cash before financing | 481.31%1.41B | -240.33%-268.61M | -132.64%-368.82M | -86.52%191.41M | 408.01%1.13B | -38.33%1.42B | 149.01%222.4M | -4.34%2.3B | -122.89%-453.78M | 545.74%2.41B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -12.35%7.75B | 49.36%24.77B | 42.15%8.84B | 35.27%16.59B | -12.32%6.22B | -47.53%12.26B | -4.88%7.09B | 74.37%23.37B | -12.81%7.46B | -29.32%13.4B |
| Refund | 5.79%-8.37B | -59.50%-24.54B | -40.43%-8.88B | -20.81%-15.39B | 7.12%-6.33B | 44.88%-12.74B | -1.96%-6.81B | -50.62%-23.11B | 33.64%-6.68B | 14.07%-15.34B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | --77.21M | --77.21M | ---- | ---- | ---- |
| Interest paid - financing | 16.16%-49.98M | -34.31%-136.53M | -264.84%-59.61M | 2.18%-101.66M | 69.33%-16.34M | 18.36%-103.92M | 8.07%-53.28M | -4.93%-127.29M | 4.15%-57.95M | 25.85%-121.31M |
| Dividends paid - financing | 11.99%-216.6M | -34.30%-561.64M | -13.92%-246.1M | 60.52%-418.2M | -11.52%-216.03M | -229,181.60%-1.06B | ---193.72M | 78.75%-462K | ---- | 99.00%-2.17M |
| Absorb investment income | ---- | --109.3M | --109.3M | ---- | ---- | ---- | ---- | 8,619.96%331.53M | ---- | 33.78%3.8M |
| Issuance expenses and redemption of securities expenses | -1,031.60%-20.88M | 87.81%-6.2M | 96.28%-1.85M | 84.38%-50.85M | 61.13%-49.53M | -125.14%-325.51M | ---127.45M | 48.18%-144.58M | ---- | -195.92%-279M |
| Other items of the financing business | ---- | ---- | ---- | 656.94%249.7M | --151.88M | -117.38%-44.83M | ---- | -307.37%-20.63M | -0.49%-8.19M | 77.87%-5.06M |
| Net cash from financing operations | -162.89%-997.16M | -222.39%-651.77M | -7.42%-379.31M | 125.22%532.53M | -190.98%-353.12M | -1,481.08%-2.11B | -119.19%-121.35M | 106.27%152.9M | 138.50%632.37M | -533.43%-2.44B |
| Effect of rate | 306.29%29.96M | 0.97%-39.07M | 83.56%-14.53M | 86.69%-39.45M | -27.90%-88.38M | -458.45%-296.43M | -1,093.50%-69.1M | 64.84%82.7M | 125.56%6.96M | 364.16%50.17M |
| Net Cash | 154.70%409.19M | -227.13%-920.37M | -196.32%-748.13M | 204.62%723.94M | 668.66%776.68M | -128.19%-692M | -43.42%101.04M | 7,952.34%2.45B | -47.51%178.59M | -238.67%-31.26M |
| Begining period cash | -32.46%2B | 30.14%2.96B | 30.14%2.96B | -30.33%2.27B | -30.33%2.27B | 351.55%3.26B | 351.55%3.26B | 2.69%721.82M | 2.69%721.82M | 0.51%702.92M |
| Cash at the end | 11.05%2.44B | -32.46%2B | -25.90%2.19B | 30.14%2.96B | -10.09%2.96B | -30.33%2.27B | 262.74%3.29B | 351.55%3.26B | -10.69%907.36M | 2.69%721.82M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.